Repaglinide for system suitability
SIAL/Y0000458 - European Pharmacopoeia (EP) Reference Standard
Synonym: Repaglinide; (S)
CAS Number: 135062-02-1
Empirical Formula (Hill Notation): C27H36N2O4
Molecular Weight: 452.59
MDL Number: MFCD00906179
Linear Formula: C27H36N2O4
Product Type: Chemical
API family | repaglinide |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C27H36N2O4/c1-4-33-25- |
InChI key | FAEKWTJYAYMJKF-QHCPKHFHSA |
manufacturer/tradename | EDQM |
SMILES string | CCOc1cc(CC(=O)N[C@@H](CC( |
storage temp. | 2-8°C |
Application: | Repaglinide for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia. |
Biochem/physiol Actions: | Repaglinide is a potent short-acting insulin secretagogue that acts by closing ATP-sensitive potassium (KATP) channels in the plasma membrane of the pancreatic beta cell. It represents a new class of insulin secretagogues, structurally unrelated to sulphonylureas, which were developed for the treatment of type 2 diabetes. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Packaging: | The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue . |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 2 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | 2-8°C |
UNSPSC | 41116107 |